{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:42:38Z","timestamp":1783690958049,"version":"3.55.0"},"reference-count":30,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s328160","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:47:16Z","timestamp":1630954036000},"page":"3787-3795","source":"Crossref","is-referenced-by-count":47,"title":["Brolucizumab in Neovascular Age-Related Macular Degeneration \u2013 Indian Real-World Experience: The BRAILLE Study"],"prefix":"10.2147","volume":"Volume 15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9693-7882","authenticated-orcid":true,"given":"Debdulal","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3590-7759","authenticated-orcid":true,"given":"Jay U","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhendu","family":"Boral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumen","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnendu","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2147\/OPTH.S33372","volume":"6","author":"Stewart","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.ophtha.2013.12.032","volume":"121","author":"Finger","year":"2014","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.ophtha.2017.10.010","volume":"125","author":"Rao","year":"2018","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"CD012208","DOI":"10.1002\/14651858.CD012208","volume":"5","author":"Li","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2174\/1573399811666150615151324","volume":"17","author":"Campa","year":"2016","journal-title":"Curr Drug Targets"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/OPTH.S236637","volume":"14","author":"Mansour","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ophtha.2020.06.028","volume":"128","author":"Dugel","year":"2021","journal-title":"Ophthalmology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40123-021-00345-2","volume":"10","author":"Chakraborty","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"ref9","unstructured":"European Medicines Agency.\u00a0ICH Topic E 2 A Clinical Safety Data Management: Definitions and Standards for Expedited Reporting; 1995.\u00a0 Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-15.pdf.\u00a0 Accessed July 9, 2021.\u00a0"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00417-020-05048-1","volume":"259","author":"Garweg","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ophtha.2017.03.057","volume":"124","author":"Dugel","year":"2017","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318672","author":"Bulirsch","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s41433-020-1111-x","volume":"35","author":"Sharma","year":"2021","journal-title":"Eye (Lond)"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamaophthalmol.2020.7085","volume":"139","author":"Enr\u00edquez","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.3390\/jcm10132758","volume":"10","author":"Bilgic","year":"2021","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Writing Committee for the UK Age-Related Macular Degeneration EMR Users Group. The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity. Ophthalmology. 2014;121(5):1092\u20131101. doi:10.1016\/j.ophtha.2013.11.031","DOI":"10.1016\/j.ophtha.2013.11.031"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"943409","DOI":"10.1155\/2013\/943409","volume":"2013","author":"Agrawal","year":"2013","journal-title":"Mediators Inflamm"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/ICU.0b013e32835f8ec0","volume":"24","author":"Johnson","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ophtha.2017.07.005","volume":"125","author":"Daien","year":"2018","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.ophtha.2020.04.017","volume":"127","author":"Baumal","year":"2020","journal-title":"Ophthalmology"},{"key":"ref22","unstructured":"Beovu\u00ae.\u00a0Post-marketing data in patients with wet AMD; 2021.\u00a0 Available from: https:\/\/www.brolucizumab.info\/post-marketing-data. Accessed July 9, 2021."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41433-020-0853-9","volume":"34","author":"Sharma","year":"2020","journal-title":"Eye (Lond)"},{"key":"ref24","first-page":"142","volume":"21","author":"Paalani","year":"2011","journal-title":"Ethn Dis"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ajo.2015.08.002","volume":"160","author":"Angeles-Han","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"ref27","first-page":"2056","volume":"61","author":"Chauhan","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e1007368","DOI":"10.1371\/journal.pgen.1007368","volume":"14","author":"Yao","year":"2018","journal-title":"PLoS Genet"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.preteyeres.2018.01.001","volume":"64","author":"Wen","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajo.2016.06.019","volume":"169","author":"Esen","year":"2016","journal-title":"Am J Ophthalmol"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=73388","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=73388","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T18:47:23Z","timestamp":1630954043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/brolucizumab-in-neovascular-age-related-macular-degeneration--indian-r-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.2147\/opth.s328160","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}